Brain-derived neurotrophic factor (BDNF) is a neurotrophin that regulates synaptic function and plasticity and plays important roles in neuronal development, survival, and brain disorders. Despite such diverse and important roles, how BDNF, or more generally speaking, neurotrophins affect synapses, particularly nerve terminals, remains unclear. By measuring calcium currents and membrane capacitance during depolarization at a large mammalian central nerve terminal, the rat calyx of Held, we report for the first time that BDNF slows down calcium channel activation, including P/Q-type channels, and inhibits exocytosis induced by brief depolarization or single action potentials, inhibits slow and rapid endocytosis, and inhibits vesicle mobilization to the readily releasable pool. These presynaptic mechanisms may contribute to the important roles of BDNF in regulating synapses and neuronal circuits and suggest that regulation of presynaptic calcium channels, exocytosis, and endocytosis are potential mechanisms by which neurotrophins achieve diverse neuronal functions.
Introduction
Molecules regulating synaptic transmission critically affect brain function. One such molecule is brain-derived neurotrophic factor (BDNF), a neurotrophin that regulates various neuronal functions via activation of tropomyosin-related kinase B (TrkB) (Reichardt, 2006) . For instance, BDNF potentiates (Kang and Schuman, 1995; Carmignoto et al., 1997) or inhibits (Tanaka et al., 1997; Frerking et al., 1998; Clark et al., 2011) synaptic transmission, enhances long-term potentiation, a cellular substrate for learning and memory (Minichiello et al., 1999) , promotes synapse formation (Vicario-Abejó n et al., 1998) , and changes the number and volume of dendritic spines (Orefice et al., 2013) . These synaptic effects may contribute to the overall effect of BDNF on neuronal survival, differentiation, axonal branching, and dendritic growth (Huang and Reichardt, 2001; Park and Poo, 2013) . Deletion of either the TrkB or Bdnf gene leads to cell atrophy, dendritic degeneration, and neuronal loss (Xu et al., 2000b; Gorski et al., 2003) . Importantly, deficiency in BDNF signaling has been implicated in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders (Zuccato and Cattaneo, 2009; Nagahara and Tuszynski, 2011; Autry and Monteggia, 2012; Li and Pozzo-Miller, 2014) . Despite the diverse and pivotal roles of BDNF in the brain, the mechanisms by which BDNF, or more generally speaking, neurotrophins regulate synaptic transmission, particularly the presynaptic component, remain poorly understood.
Here we investigated how BDNF regulates presynaptic functions at the calyx of Held, a glutamatergic nerve terminal, in which electrophysiological recordings of calcium channels, exocytosis, and endocytosis can be performed (Borst and Soria van Hoeve, 2012) . We found that BDNF inhibits calcium channel activation, exocytosis, and endocytosis. These findings are the first direct evidence of neurotrophic regulation of presynaptic functions, which may contribute to the multiple roles of neurotrophins in the brain.
Materials and Methods
Slice preparation, solutions, and electrophysiology. The measurements of presynaptic calcium current (I Ca ) and membrane capacitance (C m ) and the EPSCs were described previously (Wu et al., 2009) . Briefly, parasagittal brainstem slices (200 m thick) containing the medial nucleus of the trapezoid body (MNTB) were prepared from postnatal 7 (P7) to P14 Wistar rats of either sex. Animal protocols followed the guidelines of the National Institutes of Health. Slices were cut in an ice-cold solution containing the following (in mM): 125 NaCl, 25 NaHCO 3 , 25 dextrose, 2.5 KCl, 1.25 NaH 2 PO 4 , 0.1 CaCl 2 , 3 MgCl 2 , 0.4 ascorbic acid, 3 myoinositol, and 2 sodium pyruvate, pH 7.4 (when bubbled with 95% O 2 and 5% CO 2 ). Slices were incubated for 30 min at 37°C and then held at room temperature (22-24°C). Whole-cell presynaptic recordings were performed at room temperature using bath solution containing the following (in mM): 105 NaCl, 25 NaHCO 3 , 25 glucose, 2.5 KCl, 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgCl 2 , 0.4 ascorbic acid, 3 myo-inositol, 2 sodium pyruvate, 0.1 3,4-diaminopyridine, 0.05 D-APV, 0.001 TTX, and 20 tetraethylammonium (used to isolate I Ca ), pH 7.3 adjusted with NaOH or HCl, osmolarity: 300 -320 mOsm. The presynaptic pipette (3-5 M⍀) solution contained the following (in mM): 125 Cs-gluconate, 20 CsCl, 4 Mg-ATP, 0.3 GTP, 10 Na-phosphocreatine, 10 HEPES, and 0.05 BAPTA, pH 7.2 adjusted with CsOH (osmolarity, 300 -310 mOsm). The measurements of presynaptic I Ca and C m were made with EPC-10 amplifier and the software lock-in amplifier (PULSE; HEKA), implementing Lindau-Neher's technique (Sun and Wu, 2001) . The sinusoidal stimulus frequency was 1000 Hz with a peak-to-peak voltage Յ60 mV. The holding potential for presynaptic and postsynaptic recordings was Ϫ80 mV.
For EPSC recordings, horizontal brainstem slices containing the MNTB were prepared. The EPSC was induced by a single afferent stimulus applied via a bipolar electrode (5-20 V, 100 s) placed at the midline of the trapezoid body in which axons connected with calyces pass. The stimulation interval was 5 s. The EPSC was recorded with an Axopatch 200B amplifier (Molecular Devices) via a pipette (2-3 M⍀) containing the following (in mM): 125 K-gluconate, 20 KCl, 4 MgATP, 10 Na2-phosphocreatine, 0.3 GTP, 10 HEPES, and 0.5 EGTA, pH 7.2, adjusted with KOH. The series resistance Ͻ12 M⍀ was compensated by 90% (10 s lag).
Human recombinant BDNF (EMD Millipore) was applied in bath solution at 100 ng/ml. In some experiments, the TrkB inhibitor K252a (200 nM) was coapplied with BDNF in bath solution.
Immunohistochemistry. Brains of Bdnf LacZ/ϩ or TrkB LacZ/ϩ P14 mice were embedded in OCT (Electron Microscopy Sciences) and sectioned using a cryostat (CM3050S; Leica) at 30 m. Sections containing calyces were permeabilized with 0.3% Triton X-100 and subsequently incubated with the primary antibodies overnight at 4°C [guinea pig anti-vesicular glutamate transporter 1 (vGlut1), 1:5000 (Millipore); rabbit anti-␤-galactosidase, 1:2000 (Cappel)]. After rinses in PBS, sections were incubated with fluorescence-conjugated secondary antibodies (rhodamine-conjugated donkey anti-guinea pig and DyLight 488 donkey anti-rabbit, 1:200; Jackson ImmunoResearch) for 2 h at room temperature. Mounted sections were imaged with an inverted confocal microscope (TCS SP5II; Leica; 60ϫ oilimmersion objective, 1.4 numerical aperture). Green (excitation, 488; emission, 498 -520 nm) and red (excitation, 561; emission, 570 -620 nm) fluorescence signals were acquired sequentially. Calyx labeling by vGlut1 antibody was evident as judged by eye (Fig. 1A) .
Data analysis. Data were presented as mean Ϯ SEM and analyzed using Student's t test. Capacitance was measured within 10 min after whole-cell break-in. To avoid capacitance artifacts Yamashita et al., 2005) , capacitance jumps were measured at 200 ms after depolarization. The was measured from the monoexponential or biexponential fit. The initial rate of capacitance decay (Rate decay ) was measured within 4 s after 20 ms depolarization from Ϫ80 to 10 mV (depol 20 ms ) or 20 action potential-equivalent stimuli (APe; 1 ms depolarization from Ϫ80 to 7 mV) at 100 Hz that induced slow endocytosis but within 1-1.5 s after 10 depol 20 ms at 10 Hz (depol 20 ms ϫ 10 ) or 200 APe at 100 Hz that induced rapid endocytosis. We used depol 20 ms ϫ 10 or 200 APe at 100 Hz to induce rapid endocytosis, because the Rate decay after depol 20 ms ϫ 10 reflected mostly (ϳ80%) the rapid component of endocytosis (Wu et LacZ/ϩ (A) and TrkB in TrkB LacZ/ϩ (B) knock-in mice at P14. Scale bar, 10 m. C, Top, Averaged traces of I Ca induced by depol 20 ms in control (n ϭ 12; black) and in the presence of BDNF (100 ng/ml, n ϭ 11; red) in P8 -P10 rat calyces (mean Ϯ SEM; SEM is plotted every 2 ms). Bottom, Same traces as in the top but showing the rise phase on a larger timescale. D, I Ca 20 -80% rise time, I Ca amplitude, and QI Ca (mean Ϯ SEM) induced by depol 20 ms in control (Ctrl; n ϭ 12) and in the presence of BDNF (100 ng/ml, n ϭ 11) in P8 -P10 calyces. **p Ͻ 0.01. E, F, Similar plots as in C and D, respectively, but from P13-P14 calyces (control, n ϭ 12; BDNF, n ϭ 10). G, Sampled I Ca traces in response to 200 ms depolarization from Ϫ80 to Ϫ40 (gray), Ϫ10 (blue), 0 (pink), 10 (green), and 40 (black) mV in control and BDNF-treated calyces at P9. H, I-V relationship in control and BDNF-treated P8 -P10 calyces (n ϭ 3 for each data point).
Results

BDNF and TrkB receptor in calyces
We examined Bdnf and TrkB gene expression at calyces using Bdnf LacZ/ ϩ and Trk-B LacZ/ϩ knock-in mouse strains (Xu et al., 2000a; Gorski et al., 2003) , respectively. In these mouse strains, ␤-galactosidase expression is under control of the Bdnf or TrkB promoter. The antibody against ␤-galactosidase, which indicates Bdnf or TrkB gene expression, overlapped partially with the staining of an antibody against vGlut1 that labels the calyx of Held in Bdnf LacZ/ϩ and TrkB LacZ/ϩ knock-in mice (P14; Fig. 1 A, B) , suggesting that BDNF and TrkB are expressed in calyces. The large part of ␤-galactosidase staining did not overlap with vGlut1 staining but was observed at the postsynaptic cell body (Fig. 1A,B) , suggesting that BDNF and TrkB are also expressed in postsynaptic neurons.
BDNF slows down I Ca activation
Knowing that BDNF and TrkB are present at calyces, we examined how BDNF affects whole-cell I Ca induced by a 20 ms depolarization from Ϫ80 to 10 mV (applies if not mentioned otherwise; depol 20 ms ) in rat calyces. In control P8 -P10 rats, a depol 20 ms induced an I Ca of 2.73 Ϯ 0.10 nA (during depolarization) with a 20 -80% rise time of 0.60 Ϯ 0.03 ms (n ϭ 12 calyces). The tail current was 2.9 Ϯ 0.12 nA (n ϭ 12). In the presence of BDNF (100 ng/ml, bath application, 20 -40 min), the amplitude of I Ca induced by depol 20 ms (during depolarization, 2.66 Ϯ 0.15 nA; tail current, 3.3 Ϯ 0.18 nA, n ϭ 11) was similar to control ( p Ͼ 0.05), but the 20 -80% rise time (0.98 Ϯ 0.08 ms, n ϭ 11) was significantly slower than control ( p Ͻ 0.01; Fig. 1C,D) . A slower I Ca rise time was observed not only before hearing onset in P8 -P10 immature calyces containing P/Q-, N-, and R-type channels ( Fig. 1C,D ; Wu et al., 1998 Wu et al., , 1999 but also in more matured post-hearing P13-P14 calyces ( Fig. 1 E, F ) containing only P/Q-type channels (Iwasaki et al., 2000; Borst and Soria van Hoeve, 2012) . Thus, calcium channels affected by BDNF include P/Q type.
Calcium may facilitate or inactivate I Ca (Borst and Soria van Hoeve, 2012) . This calcium-dependent feature did not significantly affect measurements of the I Ca amplitude, because dialysis of 10 mM BAPTA in calyces did not affect peak I Ca during depol 20ms (2.45 Ϯ 0.13 nA, n ϭ 12) compared with control (2.73 Ϯ 0.10 nA, n ϭ 12, p Ͼ 0.05; Xu and Wu, 2005; Wu et al., 2009) .
To determine whether BDNF affects the calcium channel current-voltage relationship ( I-V), we applied a 200 ms depolarization from Ϫ80 to Ϫ70, Ϫ60, … to 50 mV with an interval of ϳ30 s and found that, at Ϫ10 and 0 mV, I Ca amplitude in the presence of BDNF was most significantly smaller than those in the absence of BDNF (Fig. 1G,H ) . The I-V relationship in the presence of BDNF shifted to the right compared with that in the absence of BDNF (Fig. 1H ) , consistent with a slower I Ca rise in the presence of BDNF.
BDNF inhibits exocytosis
To study how BDNF affects exocytosis, we measured the capacitance jump (⌬C m ) induced by 1-30 ms depolarization in P8 -P10 calyces in the absence (control) or presence of BDNF ( Fig. 2A-D) . In control, the ⌬C m and the I Ca charge (QI Ca ) increased as the depolarization duration increased from 1 to 5 ms, and then the ⌬C m approached saturation at longer depolarization whereas the QI Ca continued to increase (Fig. 2 A, C,D) , consistent with the finding that a readily releasable pool (RRP) is depleted by 20 -30 Figure 2 . BDNF reduces the release probability of vesicles in the RRP by reducing QI Ca . A, B, Sampled I Ca and capacitance (C m ) changes induced by 1 (pink), 2 (green), 5 (blue), and 30 (black) ms depolarization from a P9 calyx in the absence (A, Control) or presence (B) of BDNF. Capacitance within 100 ms after depolarization was not shown to avoid artifacts (Yamashita et al., 2005) . C, D, ⌬C m (C) and QI Ca (D) plotted versus the depolarization duration in the absence (control, n ϭ 9; black) or presence (n ϭ 6, mean Ϯ SEM; red) of BDNF. *p Ͻ 0.05, **p Ͻ 0.01. The dotted box on the left is enlarged on the right. E-H, Similar to A-D, respectively, but from P13-P14 calyces (control, n ϭ 5; BDNF, n ϭ 4). I, Sampled EPSCs (top) and EPSC amplitude (mean Ϯ SEM; bottom) taken 5-10 min before and 30 -40 min after applying a control solution (control; black) or BDNF (red). ms depolarization (Wu and Borst, 1999; Sakaba and Neher, 2001; Xu and Wu, 2005; Wu et al., 2009 ).
In the presence of BDNF (100 ng/ml; Fig. 2B ), the ⌬C m and QI Ca were significantly lower than control after 1-2 ms depolarization ( p Ͻ 0.01) but similar after 10 -30 ms depolarization that depletes the RRP and thus reflects its size (Fig. 2B-D) . Because BDNF did not affect the RRP, it must reduce the ⌬C m induced by 1-2 ms depolarization through reduction of the release probability of RRP vesicles. The reduction of the release probability was caused by the decrease of I Ca , given that I Ca was reduced by BDNF. Similar results were obtained in P13-P14 calyces (Fig.  2E-H ) . The decrease of I Ca induced by 1-2 ms, but not 10 -30 ms depolarization was attributable to the slowdown of I Ca rise by BDNF as shown during depol 20 ms (Fig. 1C-F ) . Thus, BDNF inhibits the release probability of the RRP vesicle during brief depolarization by reducing I Ca via slowing down the kinetics of calcium channel activation in P8 -P14 calyces.
To examine whether the presynaptic effects of BDNF have an effect on synaptic transmission, we recorded the EPSCs (see Materials and Methods) in the absence (control group) or presence (BDNF group) of BDNF. In the control group, the EPSC was 7.40 Ϯ 0.55 nA (n ϭ 3) at 5-10 min of recording but increased to 9.37 Ϯ 1.02 nA (n ϭ 3) at 30 -40 min afterward (Fig. 2I, black) . For the BDNF group, we applied BDNF after the EPSC was recorded for 5-10 min. The EPSC before BDNF application was 7.33 Ϯ 0.98 nA (n ϭ 4), similar to the control group, but decreased significantly to 5.45 Ϯ 0.52 nA (n ϭ 4, p Ͻ 0.05, paired t test) at 30 -40 min after BDNF application (Fig. 2I, red) , which was ϳ40% less compared with the control group within the same timeframe (p Ͻ 0.05). Although recording the EPSC alone is difficult to distinguish between presynaptic and postsynaptic effects of BDNF, the EPSC reduction (Fig. 2I ) was in the same order as the ⌬C m reduction (Fig. 2C) , suggesting that BDNF inhibits the EPSC by reducing vesicle release. A slightly larger extent of ⌬C m reduction might be attributable to the differences in recording conditions, such as the stimulation protocols, recording methods, and perhaps effects of BDNF on other channels or postsynaptic cells.
BDNF inhibits slow and rapid endocytosis
After exocytosis, fused vesicles are retrieved via endocytosis for recycling. Here we determined whether BDNF modulates two commonly observed forms of endocytosis: slow and rapid endocytosis (L. G. Wu et al., 2014) . In P8 -P10 calyces, 20 APe (1 ms from Ϫ80 to 7 mV; Wu et al., 2009) at 100 Hz induced a ⌬C m of 395 Ϯ 18 fF, followed by a slow monoexponential decay with a of 15.6 Ϯ 1.1 s and an initial Rate decay of 27 Ϯ 3.7 fF/s (n ϭ 6; Fig.  3 A, C) . Although both and Rate decay reflected endocytosis rate, we used mostly Rate decay because was often too slow to estimate when endocytosis is blocked (Wu et al., 2009; Sun et al., 2010) . In the presence of BDNF, the Rate decay induced by 20 APe was 6.7 Ϯ 0.8 fF/s (n ϭ 4 calyces; Fig. 3 A, C) , ϳ25% of control ( p Ͻ 0.01), suggesting that BDNF inhibits slow endocytosis.
We APe at 100 Hz (arrow) in control (Ctrl; n ϭ 6; black) and in the presence of BDNF (100 ng/ml, n ϭ 4; red) in P8 -P10 calyces (P8 -P10 applies to all panels). The averaged traces are superimposed (right), and SEM is plotted every 1 s. B, Similar arrangement as in A, except the stimulus was 200 APe at 100 Hz. Control, n ϭ 6; BDNF, n ϭ 4. C, Rate decay , QI Ca , and ⌬C m induced by 20 APe at 100 Hz in control (Ctrl; n ϭ 5) and in the presence of BDNF (n ϭ 4). *p Ͻ 0.05; **p Ͻ 0.01. D, Similar to C, except that the stimulus was 200 APe at 100 Hz. E, F, Sampled (left 3 panels) and averaged C m (right) changes induced by depol 20 ms (E) or depol 20 ms ϫ 10 (F ) in control (n ϭ 6; black), in the presence of BDNF (100 ng/ml, n ϭ 4; red), or in the presence of K252a (200 nM) and BDNF (n ϭ 4; blue). The averaged traces are superimposed (right). G, H, Rate decay , QI Ca , and ⌬C m induced by depol 20 ms (G) or depol 20 ms ϫ 10 (H ) in control (Ctrl; n ϭ 6), in the presence of BDNF (n ϭ 4), or both BDNF and K252a (200 nM, n ϭ 4).
APe induced a ⌬C m of 1190 Ϯ 76 fF, followed by a biexponential decay with of 2.05 Ϯ 0.1 s (33 Ϯ 4%) and 19.8 Ϯ 1.5 s (n ϭ 6 calyces; Fig. 3B ), respectively. The Rate decay after ⌬C m was 180 Ϯ 16 fF/s (n ϭ 6 calyces; Fig. 3D ), which reflected mostly (Ͼ80%) the rapid component of endocytosis Sun et al., 2010) . In the presence of BDNF, 200 APe induced a ⌬C m of 1000 Ϯ 119 fF and a Rate decay of 65 Ϯ 7 fF/s, which was ϳ35% of control ( p Ͻ 0.01), suggesting that BDNF inhibits rapid endocytosis (n ϭ 4 calyces; Fig. 3 B, D) .
Because endocytosis is triggered by calcium influx and the Rate decay depends on QI Ca in calyces (Hosoi et al., 2009; Wu et al., 2009; Xue et al., 2012) , the reduction of QI Ca might at least partially account for the Rate decay reduction. To determine whether a QI Ca -independent mechanism contributes to the reduced Rate decay , we used a depol 20 ms to induce slow endocytosis (Wu et al., , 2009 Sun et al., 2010) , which induced a similar QI Ca in control and BDNF-treated calyces at P8 -P10 (n ϭ 4 -6 calyces; Fig. 3 E, G; see also Fig. 1D ). The Rate decay in control was similar to that induced by 20 APe, whereas the Rate decay in the presence of BDNF was only ϳ22% of control (Fig. 3 E, G) , suggesting that BDNF inhibits endocytosis primarily by a calcium-independent mechanism. Similarly, BDNF did not reduce QI Ca but reduced the Rate decay induced by a train of 10 depol 20 ms at 10 Hz (depol 20 ms ϫ 10 ; Fig. 3F,H) , which mostly reflects (Ͼ80%) rapid endocytosis in control (Wu et al., , 2009 Sun et al., 2010) . These results suggest that BDNF inhibits rapid endocytosis primarily by a QI Ca -independent mechanism.
To determine whether the effect of BDNF on endocytosis is mediated via TrkB receptors, we applied the TrkB inhibitor K252a (200 nM, bath application), together with BDNF (100 ng/ml). In this condition, Rate decay induced by depol 20 ms or depol 20 ms ϫ 10 was similar to control, indicating that K252a blocks inhibition of endocytosis by BDNF (Fig. 3E-H) . Thus, BDNF inhibits endocytosis by activation of TrkB.
Inhibition of slow and rapid endocytosis was not only observed in P8 -P10 calyces (Fig. 3) but also in P13-P14 calyces (Fig.  4A-H ) , suggesting that BDNF inhibits endocytosis primarily by a calcium-independent mechanism in both pre-hearing and posthearing calyces.
BDNF reduced the ⌬CM induced by depol 20 ms ϫ 10 (Figs. 3H, 4H ) but not that by depol 20 ms (Figs. 3G, 4G ). The ⌬C m induced by depol 20 ms reflects the RRP size, whereas the ⌬C m induced by depol 20 ms ϫ 10 reflects the sum of all vesicles mobilized to the RRP during depol 20 ms ϫ 10 that repeatedly depletes the RRP (Wu and Borst, 1999; Sakaba and Neher, 2001; Xu and Wu, 2005; Wu et al., 2009) Figure 3A -H, respectively, but from P13-P14 calyces. A, B, Control (Ctrl), n ϭ 4; BDNF, n ϭ 4. C, D, Control, n ϭ 6; BDNF, n ϭ 4. E, F, Control, n ϭ 6; BDNF, n ϭ 4. G, H, Control, n ϭ 5; BDNF, n ϭ 4. *p Ͻ 0.05; **p Ͻ 0.01. the active zone clearance, leading to inhibition of vesicle mobilization to the RRP.
Discussion
We report for the first time that a neurotrophin, BDNF, slows down activation of voltage-dependent calcium channels, including P/Q type, at the calyx of Held nerve terminal (Fig. 1) . By capacitance measurements and postsynaptic recordings, we provided direct evidence showing that BDNF reduces release probability and the EPSCs (Fig. 2) and inhibits both slow and rapid endocytosis (Figs. 3, 4) . The effects of BDNF on release can be primarily attributed to inhibition of calcium channel activation kinetics, whereas the effects of BDNF on endocytosis is primarily calcium-independent. BDNF may also inhibit vesicle mobilization to the RRP via inhibition of endocytosis and thus the active zone clearance (Figs. 3F,H, 4F,H) . These findings show diverse regulatory roles of BDNF in presynaptic functions.
Our findings of the effects of BDNF on nerve terminals provide new mechanisms underlying diverse functions of BDNF in the nervous system, such as neuronal survival, differentiation, axonal branching, dendritic growth, synapse development, and synaptic plasticity (Huang and Reichardt, 2001 ). The reduction of release probability by BDNF may decrease synaptic strength, which may regulate synapse development and neuronal wiring. Deficiency in BDNF signaling leads to axonal atrophy and neurodegeneration, which are associated with increased intracellular calcium and excitotoxicity. Thus, inhibition of calcium influx during brief depolarization by BDNF might play a role in neuronal protection and present a potential target in treating neurodegenerative disorders.
Multiple studies show that BDNF potentiates excitatory transmission in the cortex and hippocampus, leading to a long-term potentiation (Park and Poo, 2013) . However, several studies suggest that, in the brainstem, BDNF may play a different role (Balkowiec et al., 2000; Kline et al., 2010; Clark et al., 2011) . In the medial nucleus tractus solitarius that receives cardiovascular afferent input, BDNF regulates cardiovascular responses, such as blood pressure and heart rate, by inhibiting excitatory transmission (Clark et al., 2011) . Interestingly, patients or mouse models of Rett syndrome, a neurodevelopmental disorder, exhibit decreased BDNF expression, severe autonomic dysfunctions (Wang et al., 2006; Weese-Mayer et al., 2006) , and defects in the auditory system (Pillion et al., 2003) in which the calyx of Held is crucial in sound localization (Borst and Soria van Hoeve, 2012) . Thus, BDNF might be a potential therapeutic target for Rett syndrome.
How does BDNF slow calcium channel activation and endocytosis? BDNF may activate TrkB downstream pathways, such as phospholipase C␥, that may activate Ca/calmodulin-dependent kinases, which may regulate calcium channels (Lee et al., 2003; Catterall and Few, 2008) . Understanding the TrkB downstream pathways that regulate calcium channels and endocytosis would be of a great interest in the future.
